← Back to Clinical Trials
Recruiting NCT07296939

NCT07296939 Youth Emotional and Behavioral Treatment Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07296939
Status Recruiting
Phase
Sponsor Florida State University
Condition Depression, Anxiety
Study Type INTERVENTIONAL
Enrollment 500 participants
Start Date 2026-05-07
Primary Completion 2027-05-31

Eligibility & Interventions

Sex All sexes
Min Age 4 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
Cognitive Behavioral Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 500 participants in total. It began in 2026-05-07 with a primary completion date of 2027-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to characterize key mechanisms underlying the development, maintenance, and treatment of severe irritability in a clinically heterogeneous sample of school-aged youth.

Eligibility Criteria

Inclusion Criteria: * Children between the ages of 4-17 years * (a) a principal diagnosis of an anxiety or mood disorder per DSM-5 criteria, OR (b) parent report of clinically impairing irritability, emotional dysregulation, and/or disruptive behavior in youth * Child and parent must be able to complete consent documents, assessments, and participate in treatment in English without a translator * At least one parent must be available and willing to participant in both phases. Exclusion Criteria: * Gross neurological, sensory, or motor impairment * History of seizure disorder, psychosis, or organic brain syndrome * Conditions requiring acute intervention, e.g., active suicidality * Non-English speaking child or parent

Contact & Investigator

Central Contact

Sherelle Harmon, PhD

✉ harmonylab@psy.fsu.edu

📞 18506458724

Frequently Asked Questions

Who can join the NCT07296939 clinical trial?

This trial is open to participants of all sexes, aged 4 Years or older, up to 17 Years, studying Depression, Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07296939 currently recruiting?

Yes, NCT07296939 is actively recruiting participants. Contact the research team at harmonylab@psy.fsu.edu for enrollment information.

Where is the NCT07296939 trial being conducted?

This trial is being conducted at Tallahassee, United States.

Who is sponsoring the NCT07296939 clinical trial?

NCT07296939 is sponsored by Florida State University. The trial plans to enroll 500 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology